Abstract
We read with great interest the recent review article by Adeoye et al entitled "'Search less, verify more'-Reviewing salivary biomarkers in oral cancer detection".1 The authors underscore the value of salivary biomarker panels for the early detection of oral cancer and call for their validation. We support the conclusions made concerning soluble CD44 (solCD44), an efficacious and cost-effective screening tool. We would like to add the following salient points for the consideration of your readership.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
